Dust Mites About Dust Mites and Asthma Dust mites are tiny bugs that are too small to see. Every home has dust mites. They feed on human skin flakes and are found in mattresses, pillows, carpets, upholstered furniture, bedcovers, clothes, stuffed toys, fabric, and fabric-covered items. Body parts and droppings from dust mites can trigger asthma…
Read MoreCategory: News
Second Hand Smoke and Asthma
About Secondhand Smoke and Asthma Secondhand smoke is the smoke from a cigarette, cigar, or pipe, that is exhaled by a smoker. Secondhand smoke contains more than 4,000 substances, including several compounds that cause cancer. Secondhand smoke can trigger asthma episodes and increase the severity of attacks. Secondhand smoke is also a risk factor for…
Read MoreMay is Allergy and Asthma Awareness Month
Breathe Better with Asthma, Wherever You AreIf you have asthma, you know that symptoms can come on quickly, then worsen. The things that make them do that are called triggers. An important part of managing asthma is knowing what your triggers are — at home, work, school, or while you’re outdoors. A healthcare provider can…
Read MoreAsthma Triggers
Americans spend up to 90 percent of their time indoors, and indoor allergens and irritants play a significant role in triggering asthma attacks. Triggers are things that can cause asthma symptoms, an episode or attack or make asthma worse. If you have asthma, you may react to just one trigger or you may find that…
Read MoreAAFA’s 2024 Allergy Capitals™ report names most challenging cities for living with allergies, OKC - Fifth; Tulsa - Sixth in the top Ten
Washington D.C., March 14, 2024 — The Asthma and Allergy Foundation of America (AAFA) released its 2024 Allergy Capitals™ report detailing the most challenging cities in the United States for living with allergies. The full report can be found at allergycapitals.com. This year, Wichita, Kansas takes the top spot due to its higher-than-average tree and grass…
Read MoreFDA Approves Takeda’s EOHILIA (budesonide oral suspension), the First and Only Oral Treatment in the U.S. for Eosinophilic Esophagitis (EoE)
12 Weeks of Treatment with EOHILIA May Address Significant Unmet Needs of Patients 11 Years of Age and Older EoE Is a Chronic Disease That Can Significantly Impact Patients, with Esophageal Inflammation and Intermittent Symptoms of Choking and Difficult or Painful Swallowing OSAKA, Japan and CAMBRIDGE, Massachusetts, February 12, 2024 – Takeda (TSE:4502/NYSE:TAK) today announced that…
Read More